Knockdown of Heparanase Suppresses Invasion of Human Trophoblasts by Activating p38 MAPK Signaling Pathway

Abstract EN

Preeclampsia is a pregnancy-related disease with increasing maternal and perinatal morbidity and mortality worldwide.

Defective trophoblast invasion is considered to be a major factor in the pathophysiological mechanism of preeclampsia.

Heparanase, the only endo-β-glucuronidase in mammalian cells, has been shown to be abnormally expressed in the placenta of preeclampsia patients in our previous study.

The biological role and potential mechanism of heparanase in trophoblasts remain unclear.

In the present study, stably transfected HTR8/SVneo cell lines with heparanase overexpression or knockdown were constructed.

The effect of heparanase on cellular proliferation, apoptosis, invasion, tube formation, and potential pathways in trophoblasts was explored.

Our results showed that overexpression of heparanase promoted proliferation and invasion.

Knockdown of heparanase suppressed proliferation, invasion, and tube formation but induced apoptosis.

These findings reveal that downregulation of heparanase may contribute to defective placentation and plays a crucial role in the pathogenesis of preeclampsia.

Furthermore, increased activation of p38 MAPK in heparanase-knockdown HTR8/SVneo cell was shown by MAPK pathway phosphorylation array and Western blotting assay.

After pretreatment with 3 specific p38 MAPK inhibitors (BMS582949, SB203580, or BIRB796), inadequate invasion in heparanase-knockdown HTR8/SVneo cell was rescued.

That indicates that knockdown of heparanase decreases HTR8/SVneo cell invasion through excessive activation of the p38 MAPK signaling pathway.

Our study suggests that heparanase can be a potential predictive biomarker for preeclampsia at an early stage of pregnancy and represents a promising therapeutic target for the treatment of preeclampsia.